GNE-317

SKU: orb1300413

Description

GNE-317

Research Area

Signal Transduction

Key Properties

• CAS Number: 1394076-92-6
• MW: 414.48
• Purity: 99.42%
• Formula: C₁₉H₂₂N₆O₃S
• SMILES: COC1(COC1)c1sc2c(nc(nc2c1C)-c1cnc(N)nc1)N1CCOCC1
• Target: PI3K,mTOR
• Solubility: DMSO:12.5 mg/mL (30.16 mM)

Bioactivity

• In Vivo:
  Mice, which are i.c. inoculation with GL261-GFP-Luc cells Seven days later,are treated once daily wit the maximum tolerated dose of GDC-0980 (7.5 mg/kg), GNE-317 (30 mg/kg), or Vehicle. Tumor growth is tracked in GL261 through bioluminescence imaging on a weekly basis. There are no significant differences in GL261 tumor growth amon the 3 groups treated by GDC-0980, GNE-317 or Vehicle the data show tha the drugs have limited efficacy in inducing cell death in the GL261 cell line. Although GNE-317 has greater delivery and enhanced therapeutic targeting efficacy, it is not effective in the treatment o the GL261 tumor.
• In Vitro:
  GNE-317, an oxetane derivative synthesized by GDC-0980, is aimed at reducing substratee affinity for efflux transporters. In vitro GDC-0980 demonstrate similar profiles with GNE-317 in MTS cytotoxicity experiments usin the GL261 cell line.
• Cell Research:
  Cellular viability assays are set up in a 96-well format with 2000 GL261-GFP-Luc cells plated per well in the culture conditions. GL261, an aggressive C57BL/6J-derived glioma line, is transfected with both green fluorescent protein (GFP) and luciferase (Luc) from separate plasmids.GL261-GFP-Luc cells are cultured in Dulbecco's modified Eagle's medium supplemented with 10% FBS and Penicillin/Streptomycin (100 U/mL) at 5% oxygen, and are selected by 4 mg mL Puromycin and 4 mg mL G418. Suspend GNE-317 in DMSO and then diluted wit the medium.GL261-GFP-Luc cells are incubated in the presence of drug or Vehicle for 48 hours, and viability was assessed by MTS assay. Results were detected using a Synergy Mx automated plate reader,which are set up absorbance at 490 nM and used to determine viability and at 650 nM to account fo the background. Numerical Values from drug-treated wells are normalized to the Values of Vehicle-treated wells to yfield percent survival.
• Animal Research:
  7-week-old C57BL/6J mice are implanted GL261-GFP-Luc cells. When tumors Each 5e7 photons/s/cm2/sr (radiance), mice are orally administere the maximum tolerate the dose,which is defined as < 0% drop in mice bodyweight dose, GDC-0980 for 7.5 mg/kg, GNE-317 for 30 mg/kg or Vehicle once daily for 3 days. At 1 or 6 hours afte the third dose, mice are euthanized with carbon dioxide and perfused with 30 mL PBS.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Disclaimer: For research use only

Alternative Names

Mammalian target of Rapamycin, GNE 317, GNE-317, GNE317, inhibit, mTOR, Inhibitor, PI3K, Phosphoinositide 3-kinase

Compound Identifiers

PubChem CID

70676303